Hormone Receptor Signaling and Breast Cancer Resistance to Anti-Tumor Immunity.

Moisand, Alexandra; Madéry, Mathilde; Boyer, Thomas; Domblides, Charlotte; Blaye, Céline; Larmonier, Nicolas

Moisand, Alexandra; Madéry, Mathilde; Boyer, Thomas; Domblides, Charlotte; Blaye, Céline; Larmonier, Nicolas.

Afiliación

Moisand A; CNRS UMR 5164, ImmunoConcEpT, Biological and Medical Sciences Department, University of Bordeaux, 33076 Bordeaux, France.
Madéry M; Cancer Biology Graduate Program, UB Grad 2.0, University of Bordeaux, 33076 Bordeaux, France.
Boyer T; CNRS UMR 5164, ImmunoConcEpT, Biological and Medical Sciences Department, University of Bordeaux, 33076 Bordeaux, France.
Domblides C; Cancer Biology Graduate Program, UB Grad 2.0, University of Bordeaux, 33076 Bordeaux, France.
Blaye C; CNRS UMR 5164, ImmunoConcEpT, Biological and Medical Sciences Department, University of Bordeaux, 33076 Bordeaux, France.
Larmonier N; Cancer Biology Graduate Program, UB Grad 2.0, University of Bordeaux, 33076 Bordeaux, France.

Int J Mol Sci ; 24(20)2023 Oct 10.

Article en En | MEDLINE | ID: mdl-37894728

Asunto(s)

Neoplasias de la Mama; Humanos; Femenino; Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/metabolismo; Calidad de Vida; Recurrencia Local de Neoplasia; Transducción de Señal; Estrógenos; Receptores de Progesterona/metabolismo; Resistencia a Antineoplásicos

Palabras clave

breast cancers; cancer immunity; estrogen receptors; hormone receptors; hormone signaling; immunotherapies

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google